Showing results (71-80 of 212) with videos related to

Sort By:
Pageof 22
Medical Mycology|December 31, 2020
Clinical considerations on posaconazole administration and therapeutic drug monitoring in allogeneic hematopoietic cell transplant recipientsMateja Kraljevic, Nina Khanna, Michael Medinger, et al.
Open Forum Infectious Diseases|July 25, 2020
Optimal Treatment Duration of Pseudomonas aeruginosa Infections in Allogeneic Hematopoietic Cell Transplant RecipientsFlaminia Olearo, Ilona Kronig, Stavroula Masouridi-Levrat, et al.
Frontiers in Immunology|January 30, 2023
Human pegivirus-1 replication influences NK cell reconstitution after allogeneic haematopoietic stem cell transplantationAmandine Pradier, Samuel Cordey, Marie-Céline Zanella, et al.
Leukemia & Lymphoma|April 4, 2013
Azacytidine for acute myeloid leukemia in elderly or frail patients: a phase II trial (SAKK 30/07)Jakob R Passweg, Thomas Pabst, Sabine Blum, et al.
Haematologica|March 23, 2011
Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipientsBilal Mohty, Michael Bel, Marija Vukicevic, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|September 15, 2023
Revisiting Cytomegalovirus Serology in Allogeneic Hematopoietic Cell Transplant RecipientsVera Portillo, Stavroula Masouridi-Levrat, Léna Royston, et al.
Plos One|January 24, 2013
Autologous bone marrow mononuclear cell transplantation in patients with decompensated alcoholic liver disease: a randomized controlled trialLaurent Spahr, Yves Chalandon, Sylvain Terraz, et al.
Bone Marrow Transplantation|April 21, 2023
Effect of pharmacokinetics and pharmacogenomics in adults with allogeneic hematopoietic cell transplantation conditioned with BusulfanClaire Seydoux, Chakradhara Rao Satyanarayana Uppugunduri, Michael Medinger, et al.
Frontiers in Immunology|June 16, 2020
Torque Teno Virus as a Potential Biomarker for Complications and Survival After Allogeneic Hematopoietic Stem Cell TransplantationAmandine Pradier, Stavroula Masouridi-Levrat, Carine Bosshard, et al.
Pediatric Transplantation|December 14, 2011
Third-party mesenchymal stromal cell infusion is associated with a decrease in thrombotic microangiopathy symptoms observed post-hematopoietic stem cell transplantationMarc Ansari, Dirk Strunk, Katharina Schallmoser, et al.
Pageof 22